In October, the FDA approved ustekinumab to treat patients 12 years or older who have moderate to severe plaque psoriasis…
Trump Panel Urges More Treatment Options to Fight Opioid Crisis
(Reuters)—A panel convened by U.S. President Donald Trump to tackle the opioid crisis called on Wednesday for more treatment programs, tighter prescribing guidelines and additional drug courts to help reduce overdose deaths. The commission, led by New Jersey Governor Chris Christie, said the recommendations would require funding by Congress but did not recommend an amount….
Obamacare 2018 Enrollment Clouded by Uncertainty under Trump
WASHINGTON (Reuters)—As Americans begin signing up for Obamacare health insurance plans on Wednesday, experts expect reduced participation as a bitter political debate clouds the program’s future. Republicans in Congress have repeatedly failed to repeal and replace former President Barack Obama’s healthcare law, which they have said drives up costs for consumers and interferes with personal…
Puerto Rico Seeks Help as Medicaid Crisis Deepens after Maria
WASHINGTON/SAN FRANCISCO (Reuters)—Puerto Rico, still reeling from Hurricane Maria, is asking the Trump administration and U.S. lawmakers for help in staving off a Medicaid crisis that has put a quarter of the island’s residents at risk of losing medical care. The territory, which has grappled for years with shortfalls in funding of its Medicaid healthcare…
New Jersey Sues OxyContin Maker, Links Marketing to Opioid Crisis
(Reuters)—New Jersey on Tuesday sued Purdue Pharma LP, accusing the OxyContin maker of contributing to the state’s opioid crisis through deceptive marketing to doctors and patients, including the elderly and the “opioid-naive.” Christopher Porrino, the New Jersey attorney general, faulted what he called a decade-long marketing campaign of “almost inconceivable callousness and irresponsibility, and said…
ACR Monitoring Saline Supply Shortage Due to Hurricanes in Puerto Rico
The ACR is aware of the shortage of intravenous saline solutions produced in Puerto Rico that is beginning to emerge across the U.S. and in rheumatology practices. In September, Hurricanes Irma and Maria wreaked havoc on the island, wiping out the island’s power grid and greatly hindering saline solution production. Puerto Rico produces about 10%…
AMA Workshop Focuses on Alternative Payment Models
On Oct. 4 in Chicago, the AMA hosted its second workshop on alternative payment models (APMs). The conference room was packed with providers and staff from specialty societies ready to listen to a whole day’s worth of APM presentations from professionals in the field. To kick off the meeting, AMA President-Elect Barbara McAneny, MD, welcomed…
ACR Advocates for Affordable Drugs & Consultation Codes
An ACR delegation will propose two new resolutions on issues affecting practicing rheumatologists and their patients at the American Medical Association Interim Meeting of the House of Delegates in Honolulu Nov. 11–14. These proposals promote transparency of pharmacy benefit manager (PBM) practices and the protection of private payer consultation codes. Resolution 810 The ACR is…
Payer Advocacy: The CORC/ISC Is Working for Your Practice
One of the least recognized, most important (certainly for rheumatologists in the U.S. running their own practice), and hardest working committees at the ACR is the Insurance Subcommittee (ISC). Currently chaired by Sean Fahey, MD, and managed by ACR staff liaison Meredith Strozier, this group of dedicated volunteers monitors the insurance landscape, fields complaints from…
Lupus Survival Is Improving Slowly
NEW YORK (Reuters Health)—Systemic lupus erythematosus (SLE) mortality has declined during the past 46 years in the U.S.—but more slowly than mortality in the general population, according to a nationwide study. “Based on our experience in the clinic and according to previous reports showing improvement in the short-term (five- to 10-year) survival in lupus, I…
- « Previous Page
- 1
- …
- 168
- 169
- 170
- 171
- 172
- …
- 310
- Next Page »